US obesity rates decline for 1st time in more than a decade

Eli Lilly and Novo Nordisk will kick off a massive shopping spree in 2025. The two obesity giants will be sitting on cash ...
A new study reveals that modulating endocannabinoids in the brain can reduce food intake and boost physical activity, ...
Obesity is down in the US for the first time in a decade. A new study suggests weight-loss drugs may explain why.
Endocannabinoids in the brain play a key role in food intake and energy use. Modulating the action of these molecules could help fight obesity, say researchers.
A new study published in the JAMA Health Forum found that obesity rates dropped from 46% in 2022 to 45.6% in 2023. The study ...
The global obesity epidemic represents one of the most pressing public health challenges of our time. With nearly ...
Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...
Obesity continues to take a dramatic toll on the hearts of men, according to a recent report from the American Heart ...